Pyrazole derivatives for the treatment of cystic fibrosis
US-12492193-B2 · Dec 9, 2025 · US
This page is not indexed by search engines while we improve data quality.
Bertozzi Fabio patents
Bertozzi Fabio is listed as an inventor on 22 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Bertozzi Fabio |
| Total patents | 22 |
| First publication | Mar 10, 2016 |
| Latest publication | Dec 9, 2025 |
Notable patents
Publications ranked by popularity score, then publication date.
Compounds and compositions for the treatment of cystic fibrosis
US-12391680-B2 · Aug 19, 2025 · US
Compounds and compositions for the treatment of cystic fibrosis
US-11999734-B2 · Jun 4, 2024 · US
Method for the preparation of pyrazole derivatives as modulators of cftr protein
US-2024140936-A1 · May 2, 2024 · US
Pyrazole derivatives for the treatment of cystic fibrosis
US-2023212157-A1 · Jul 6, 2023 · US
Pyrazole derivatives for the treatment of cystic fibrosis
US-11597723-B2 · Mar 7, 2023 · US
Compounds and compositions for the treatment of cystic fibrosis
US-2022089584-A1 · Mar 24, 2022 · US
Compounds and compositions for the treatment of cystic fibrosis
US-2021292324-A1 · Sep 23, 2021 · US
Compounds and compositions for the treatment of cystic fibrosis
US-10968225-B2 · Apr 6, 2021 · US
Therapeutically active bicyclic-sulphonamides and pharmaceutical compositions
US-10865194-B2 · Dec 15, 2020 · US
Recent patents
Latest publications not already listed above.
Compounds and compositions for the treatment of cystic fibrosis
US-2020369663-A1 · Nov 26, 2020 · US
Heterocyclic derivatives for the treatment of cystic fibrosis
US-10745407-B2 · Aug 18, 2020 · US
Pyrazole derivatives for the treatment of cystic fibrosis
US-2020131157-A1 · Apr 30, 2020 · US
Heterocyclic derivatives for the treatment of cystic fibrosis
US-2020002348-A1 · Jan 2, 2020 · US
Modulation of N-acylethanolamine-hydrolysing acid amidase (NAAA) for disease treatment
US-10364242-B2 · Jul 30, 2019 · US
Therapeutically active bicyclic-sulphonamides and pharmaceutical compositions
US-2019135778-A1 · May 9, 2019 · US
Modulation of n-acylethanolamine-hydrolysing acid amidase (naaa) for disease treatment
US-2019135802-A1 · May 9, 2019 · US
Amide derivatives of lactam based N-acylethanolamine acid amidase (NAAA) inhibitors
US-9908848-B2 · Mar 6, 2018 · US
Carbamate derivatives of lactam based N-acylethanolamine acid amidase (NAAA) inhibitors
US-9828338-B2 · Nov 28, 2017 · US
Disubstituted beta-lactones as inhibitors of N-acylethanolamine acid amidase (NAAA)
US-9353075-B2 · May 31, 2016 · US
Carbamate derivatives of lactam based n-acylethanolamine acid amidase (naaa) inhibitors
US-2016068482-A1 · Mar 10, 2016 · US
Amide derivatives of lactam based n-acylethanolamine acid amidase (naaa) inhibitors
US-2016068483-A1 · Mar 10, 2016 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Fondazione St Italiano Tecnologia | 19 |
| St Giannina Gaslini | 12 |
| Fond Per La Ricerca Sulla Fibrosi Cistica Onlus | 8 |
| Univ California | 5 |
| Fond Per La Ricerca Sulla Fibrosi Cistica—Onlus | 5 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61P11/00 | 13 |
| C07D405/12 | 12 |
| C07D471/04 | 10 |
| C07D413/12 | 9 |
| C07D498/04 | 8 |